Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Insilicos is a Seattle-based bioinformatics company specializing in the development of high-performance software for proteomics and mass spectrometry data analysis. The company's flagship product, the Insilicos Proteomics Pipeline (IPP), provides an automated environment for the identification and quantification of proteins in complex biological samples. By integrating advanced statistical algorithms and search engines, Insilicos enables researchers to improve the accuracy and reproducibility of biomarker discovery and protein characterization. The firm is well-regarded for its contributions to the open-source community, particularly through its collaboration with the Institute for Systems Biology on the Trans-Proteomic Pipeline (TPP). Insilicos serves a global client base across the biotechnology, pharmaceutical, and academic sectors, providing both software licenses and specialized consulting services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Insilicos.